Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment

Biology of Blood and Marrow Transplantation

Volumn 3, Issue 6, 1997, Pages 316-323

  Glück, Stefan ^a   Ross, Amy A ^b   Layton, Tamara J ^b   Ostrander, Anita B ^b   Goldstein, Lynn C ^b   Porter, Kathy ^a   Ho, Anthony D ^c  

^a Northeastern Ontario Regional Cancer Centre   (Canada)

^b Cell Pro Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Leukapheresis; Stem cell transplant; Tumor contamination

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BREAST TUMOR; CELL COUNT; CLINICAL TRIAL; CLONOGENIC ASSAY; CYTOLOGY; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKAPHERESIS; METHODOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RETROSPECTIVE STUDY; STEM CELL; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL COUNT; COLONY-FORMING UNITS ASSAY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKAPHERESIS; MIDDLE AGED; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; STEM CELLS; TREATMENT OUTCOME;

EID: 0031298773     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993.
2. Vredenburgh JJ, Peters WP, Rosner G, De Sombre K, Johnston WW, Kamel A, Wu K, Bast RC Jr: Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy. Bone Marrow Transplant 16:6924, 1995.
3. Kessinger A, Armitage J, Bierman P, Bishop M, Joshi S, Reed E, Sharp G, Talmadge J, Vose J: Clinical outcome of peripheral blood stem cell support. Med Oncol 11:43, 1994.
4. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumour cells and haematopoietic progenitor cells into peripheral blood of patients with solid tumours. Blood 83:636, 1994.
5. Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MA, Kay N, Van Ness B: Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood 11:3021, 1991.
6. Hardingham JE, Kotasek D, Sage RE, Dobrovic A, Gooley T, Dale BM: Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 11:15, 1993.
7. Berinstein NL, Reis MD, Ngan BY, Sawka CA, Jamal HH, Kuzniar B: Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma. J Clin Oncol 11:1344, 1993.
8. Negrin RS, Pesando J: Detection of tumour cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. J Clin Oncol 12:1021, 1994.
9. Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN, Brenner MK: Direct demonstration that autologous bone marrow transplantation for solid tumours can return a multiplicity of tumorigenic cells. Blood 84:380, 1994.
10. Moss TJ, Sanders DG: Detection of neuroblastoma cells in blood. J Clin Oncol 8:736, 1990.
11. Moss TJ, Ross AA: The risk of tumour cell contamination in peripheral blood stem cell collections. J Hematother 1:225, 1992.
12. Moss TJ, Cairo MS, Bostrom B, Kletzel M, Kreissman S, Sender L, Cooper B, Lazarus HM, Kennedy MJ, Meagher R, Herzig RM, Ross AA: Using bone marrow (BM) immunocytochemical (ICC) analysis to determine optimal timing of peripheral blood stem cell (PBSC) harvest for patients with breast cancer and neuroblastoma. Blood 84:354a, 1994. [abstract]
13. Moss TJ, Cairo M, Santana VM, Weinthal J, Hurtvitz C, Bostrom B: Clonogenicity of circulating neuroblastoma cells: implications regarding peripheral blood stem cell transplantation. Blood 83:3085, 1994.
14. Ross AA, Loudovaris M, Hazelton B, Weaver CH, Schwartzberg L, Bender JG: Immunocytochemical analysis of tumour cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patients. Exp Hematol 23:1478, 1995.
15. Simpson SJ, Vachula M, Kennedy MJ, Kaizer H, Coon JS, Ghalie R, Williams S, Van Epps D: Detection of tumour cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp Hematol 23:1052, 1995.
16. Datta YH, Adamas PT, Drobyski WR, Ethier SP, Terry VH, Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475, 1994.
17. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14:1868, 1996.
18. 7. Proc Natl Acad Sci USA 92:537, 1995.
19. Vredenburgh JJ, Silva O, Tyer C, De Sombre K, Abou-Ghalia A, Cook M, Layfield L, Peters WP, Bast RC Jr: A comparison of immunohistochemistiy, two-colour immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrow. J Hematother 5:57, 1996.
20. Passos-Coelho JL, Ross AA, Davis JM, Huelskamp AM, Clark B, Noga SJ, Davidson NE, Kennedy MJ: Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxy cyclophosphamide. Cancer Res 54:2366, 1994.
21. Passos-Coelho JL, Ross AA, Kahn DJ, Moss TJ, Davis JM, Huelskamp AM, Noga SJ, Davidson NE, Kennedy MJ: Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with haematopoietic growth factor alone or after cyclophosphamide followed by growth factor. J Clin Oncol 14:2569, 1996.
22. Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N, Nadler LM: Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81:3449, 1993.
23. Ho AD, Glück S, Germond C, Sinoff C, Dietz G, Maruyama M, Corringham RET: Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 11:1738, 1993.
24. Glück S, Porter K, Chadderton T, Maruyama M: Detection of DMSO (dimethylsulfoxide) prior to autografting after high-dose chemotherapy for metastatic breast cancer. Blood 82 (Suppl 1):430a, 1993. [abstract]
25. Glück S, Des Rochers C: High-dose chemotherapy followed by blood cell transplantation: a safe and effective outpatient approach. Bone Marrow Transplant, 1997. In press.
26. Akard LP, Wiemann M, Thompson JM, Swinney M, Lynn K, Hanks S, Jansen J: Impaired stem cell collection by consecutive courses of high-dose mobilizing chemotherapy using cyclophosphamide, etoposide, and G-CSF. J Hematother 5:271, 1996.
27. Freedman AS, Gribben JG, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Pandite L, Robertson MJ, Kroon M, Ritz J, Nadler LM: High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 88:2780, 1996.
28. Chen L, Pulsipher M, Chen D, Sieff C, Elias A, Fine HA, Kufe DW: Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest 98:2539, 1996.
29. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994.
30. Kennedy MJ, Davis J, Passos-Coelho J, Noga SJ, Huelskamp AM, Ohly K, Davidson NE: Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer. Cancer Res 53:5424, 1993.
31. Champlin R, Ball E, Holland K, LeMaistre CF, Jacobs C, Shpall EJ: Importance of cell dose with CD34-selected autologous marrow transplants: results of a controlled trial. Blood 86 (Suppl):293a, 1995. [abstract]
32. Franklin WA, Shpall EJ, Archer P, Johnston CS, Garza-Williams S, Hami L, Bitter MA, Bast RC, Jones RB: Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Breast Cancer Res Treat 41:1, 1996.